Aptus Capital Advisors’s Inspire Corporate Bond ETF IBD Stock Holding History

Aptus Capital Advisors’s Portfolio IBD Stock Details IBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.45K	Buy	+61	New	+$1.46K	﹤0.01%	1740

Other funds holding IBD

Inspire Advisors Meridian, Idaho $1.44B AUM 26.8% 1-Year Est. Return

Faithward Advisors Lancaster, Pennsylvania $819M AUM 41.44% 1-Year Est. Return

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bare Financial Services Gap, Pennsylvania $436M AUM 20.22% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.43B AUM 49.04% 1-Year Est. Return

OneAscent Financial Services Birmingham, Alabama $2.09B AUM 24.1% 1-Year Est. Return

PAX Financial Group San Antonio, Texas $673M AUM 21.2% 1-Year Est. Return

Plan A Wealth Lincoln, Nebraska $235M AUM 22.68% 1-Year Est. Return

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Aptus Capital Advisors's IBD Position: Q2 2026 in Review

Aptus Capital Advisors opened a new position in Inspire Corporate Bond ETF (IBD) in Q2 2026: 61 shares worth $1.45K. The stake represents ﹤0.01% of the portfolio and ranks #1740 among its holdings.

110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

Aptus Capital Advisors held 61 shares of Inspire Corporate Bond ETF worth $1.45K as of Q2 2026.
Inspire Corporate Bond ETF was a new Aptus Capital Advisors position in Q2 2026.
Inspire Corporate Bond ETF made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #1740 holding.
110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.